Diseases, Conditions, Syndromes

Recombinant vaccine confers more protection against influenza

A high-dose recombinant influenza vaccine is more effective than standard-dose vaccine among adults aged 50 to 64 years, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.

page 1 from 9